Jason Hanna studies oncogenic signaling, tumor plasticity, and non–cell-autonomous mechanisms in vascular and fusion‑driven sarcomas. His work integrates genomics with mechanism, develops endothelial and preclinical models, and advances translational strategies, including selective small‑molecule antimetastatic candidates.